California AB1864 mandates nucleic acid synthesis screening for providers and manufacturers in the state.
California AB1864 requires manufacturers and providers of synthetic nucleic acids to adhere to the Framework for Nucleic Acid Synthesis Screening, issued by the National Science and Technology Council's Fast Track Action Committee. Providers must attest to compliance and post this attestation publicly. Violations incur civil penalties up to $5,000 per day, recoverable by the Attorney General. The act does not regulate customers' activities unrelated to providing or manufacturing.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.